ZLAB Relative Valuation
ZLAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ZLAB is overvalued; if below, it's undervalued.
Historical Valuation
Zai Lab Ltd (ZLAB) is now in the Undervalued zone, suggesting that its current forward PS ratio of 6.02 is considered Undervalued compared with the five-year average of -14.09. The fair price of Zai Lab Ltd (ZLAB) is between 466.45 to 475.07 according to relative valuation methord. Compared to the current price of 33.57 USD , Zai Lab Ltd is Undervalued By 92.8%.
Relative Value
Fair Zone
466.45-475.07
Current Price：33.57
92.8%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
4.49
P/B
Median3y
1.25
Median5y
1.02
-4.84
FCF Yield
Median3y
-10.60
Median5y
-8.95
Competitors Valuation Multiple
The average P/S ratio for ZLAB's competitors is 322.33, providing a benchmark for relative valuation. Zai Lab Ltd Corp (ZLAB) exhibits a P/S ratio of 6.11, which is -98.10% above the industry average. Given its robust revenue growth of 22.19%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Zai Lab Ltd (ZLAB) currently overvalued or undervalued?
What is Zai Lab Ltd (ZLAB) fair value?
How does ZLAB's valuation metrics compare to the industry average?
What is the current P/B ratio for Zai Lab Ltd (ZLAB) as of Jul 20 2025?
What is the current FCF Yield for Zai Lab Ltd (ZLAB) as of Jul 20 2025?
What is the current Forward P/E ratio for Zai Lab Ltd (ZLAB) as of Jul 20 2025?